AR019274A1 - Uso de nanodispersiones en formulaciones farmaceuticas finales - Google Patents
Uso de nanodispersiones en formulaciones farmaceuticas finalesInfo
- Publication number
- AR019274A1 AR019274A1 ARP990102160A ARP990102160A AR019274A1 AR 019274 A1 AR019274 A1 AR 019274A1 AR P990102160 A ARP990102160 A AR P990102160A AR P990102160 A ARP990102160 A AR P990102160A AR 019274 A1 AR019274 A1 AR 019274A1
- Authority
- AR
- Argentina
- Prior art keywords
- pharmaceutical formulations
- alpha
- final pharmaceutical
- nanodispersions
- nanodispersion
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Dispersion Chemistry (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Nanotechnology (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Se proporciona una descripcion del uso de nanodispersion, que comprende. (a) una molécula que forma la membrana, (b) un coemulsionante, y (c) un componentelipofílico, en formulaciones farmacéuticas finales; la nanodispersion se puede obtener: (alfa)mezclando los componentes (a), (b) y (c) hasta que se obtiene unlíquido claro homogéneo, y (beta) agregando el líquido obtenido en el paso (alfa) a la fase acuosa de las formulaciones farmacéuticas finales; los pasos (alfa)y (beta) se llevan a cabo sin ningun suministro adicional de energía. Las nanodispersiones utilizadas de acuerdo con la presente son adecuadas como vehículosde transporte para agentes activos farmacéuticos.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98810422 | 1998-05-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR019274A1 true AR019274A1 (es) | 2002-02-13 |
Family
ID=8236078
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP990102160A AR019274A1 (es) | 1998-05-11 | 1999-05-07 | Uso de nanodispersiones en formulaciones farmaceuticas finales |
Country Status (20)
Country | Link |
---|---|
US (2) | US7081253B2 (es) |
EP (1) | EP0956853B1 (es) |
JP (1) | JP4755742B2 (es) |
KR (1) | KR100622285B1 (es) |
CN (1) | CN1220483C (es) |
AR (1) | AR019274A1 (es) |
AT (1) | ATE312597T1 (es) |
AU (1) | AU767896B2 (es) |
BR (1) | BRPI9902068B8 (es) |
CZ (1) | CZ166999A3 (es) |
DE (1) | DE59912910D1 (es) |
ES (1) | ES2253871T3 (es) |
HU (1) | HUP9901570A2 (es) |
ID (1) | ID22565A (es) |
MY (1) | MY133019A (es) |
PL (1) | PL332934A1 (es) |
RU (1) | RU2224505C2 (es) |
SG (1) | SG71923A1 (es) |
TW (1) | TWI241915B (es) |
ZA (1) | ZA993200B (es) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9908309D0 (en) * | 1999-04-12 | 1999-06-02 | Phares Pharm Res Nv | Lipid aggregate forming compositions and their use |
FR2805761B1 (fr) * | 2000-03-02 | 2002-08-30 | Mainelab | Nanocapsules lipidiques, procede de preparation et utilisation comme medicament |
TW586945B (en) * | 2001-01-12 | 2004-05-11 | Novartis Ag | Lens care product containing dexpanthenol |
US20030113366A1 (en) * | 2001-12-14 | 2003-06-19 | Macgregor Alexander | Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents |
AT6609U3 (de) * | 2003-04-07 | 2004-04-26 | Unipack Ges M B H Abfuell Und | Verfahren zum herstellen einer klaren lecithin enthaltenden oralen zubereitung |
ITMI20032019A1 (it) * | 2003-10-17 | 2005-04-18 | Fidia Farmaceutici | Microemulsioni di retinoidi e composizioni farmaceutiche che le contengono |
TWI350183B (en) * | 2003-12-31 | 2011-10-11 | Ind Tech Res Inst | A liposome and a preparation method |
AU2005249274B2 (en) * | 2004-06-04 | 2011-02-24 | Camurus Ab | Liquid depot formulations |
US20060198891A1 (en) * | 2004-11-29 | 2006-09-07 | Francois Ravenelle | Solid formulations of liquid biologically active agents |
DE112006001898B4 (de) * | 2005-07-21 | 2013-05-08 | National Institute For Materials Science | Vorrichtung zur Inhalation von Arzneimitteln |
US9839667B2 (en) | 2005-10-14 | 2017-12-12 | Allergan, Inc. | Prevention and treatment of ocular side effects with a cyclosporin |
US7745400B2 (en) | 2005-10-14 | 2010-06-29 | Gregg Feinerman | Prevention and treatment of ocular side effects with a cyclosporin |
NZ572601A (en) | 2006-03-29 | 2012-03-30 | Univ Wayne State | Liposomal nanoparticles and other formulations of fenretinide for use in therapy and drug delivery |
JP4840031B2 (ja) | 2006-08-31 | 2011-12-21 | ソニー株式会社 | ナビゲーション装置、ナビゲーション処理方法及びナビゲーション処理プログラム |
EP1938801A1 (en) * | 2006-12-22 | 2008-07-02 | Biofrontera Bioscience GmbH | Nanoemulsion |
CL2008000037A1 (es) * | 2007-01-16 | 2008-10-10 | Bayer Consumer Care Ag | Solucion coloidal que comprende al menos un ingrediente activo, al menos una molecula formadora de membrana y al menos un componente espumante; procedimiento para fabricar la solucion coloidal; y su uso para tratar trastornos dermatologicos. |
US8309129B2 (en) | 2007-05-03 | 2012-11-13 | Bend Research, Inc. | Nanoparticles comprising a drug, ethylcellulose, and a bile salt |
US8703204B2 (en) | 2007-05-03 | 2014-04-22 | Bend Research, Inc. | Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and anon-ionizable polymer |
US8974827B2 (en) | 2007-06-04 | 2015-03-10 | Bend Research, Inc. | Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer |
US9545384B2 (en) | 2007-06-04 | 2017-01-17 | Bend Research, Inc. | Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glocol succinate |
EP2231169B1 (en) | 2007-12-06 | 2016-05-04 | Bend Research, Inc. | Pharmaceutical compositions comprising nanoparticles and a resuspending material |
WO2009073216A1 (en) | 2007-12-06 | 2009-06-11 | Bend Research, Inc. | Nanoparticles comprising a non-ionizable polymer and an amine-functionalized methacrylate copolymer |
CN100536826C (zh) * | 2007-12-28 | 2009-09-09 | 清华大学 | 一种绵羊油纳米乳液及其制备方法和应用 |
US20110033545A1 (en) * | 2009-08-06 | 2011-02-10 | Absize, Inc. | Topical pharmaceutical preparations having both a nanoparticle solution and a nanoparticle suspension and methods for the treatment of acute and chronic pain therewith |
FR2949063B1 (fr) * | 2009-08-11 | 2011-09-30 | Pf Medicament | Composition pharmaceutique comprenant un ester de dha destinee a etre administree par voie parenterale |
DE202010004750U1 (de) | 2010-04-09 | 2011-10-11 | Biofrontera Bioscience Gmbh | Pharmazeutische oder/und kosmetische Zusammensetzung zur Behandlung der Haut |
CN102277748A (zh) * | 2010-06-12 | 2011-12-14 | 罗莱家纺股份有限公司 | 纳米维生素微胶囊整理剂的使用方法 |
KR101494594B1 (ko) * | 2011-08-30 | 2015-02-23 | 주식회사 종근당 | 약리학적 활성물질의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물 |
KR101586789B1 (ko) | 2012-12-28 | 2016-01-19 | 주식회사 종근당 | 양이온성 약리학적 활성물질의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물 |
KR101586790B1 (ko) | 2012-12-28 | 2016-01-19 | 주식회사 종근당 | 음이온성 약리학적 활성물질의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물 |
KR101586791B1 (ko) | 2012-12-28 | 2016-01-19 | 주식회사 종근당 | GnRH 유도체의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물 |
EP3583954A1 (en) * | 2018-06-19 | 2019-12-25 | neubourg skin care GmbH | Nanodispersions of birch bark extract, electrospun fibers containing such nanodispersions and their use for the treatment of wounds |
CN111388744B (zh) * | 2020-01-15 | 2021-05-18 | 华中科技大学 | 一种凝胶贮库及其制法与制备术后止血制剂的应用 |
WO2022005169A1 (ko) | 2020-06-30 | 2022-01-06 | 주식회사 종근당 | Gnrh 유도체를 포함하는 주사용 조성물 |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3150990A1 (de) | 1981-12-23 | 1983-06-30 | A. Nattermann & Cie GmbH, 5000 Köln | Neue pflanzenschutzmittelsuspensionskonzentrate |
US4675193A (en) * | 1983-10-31 | 1987-06-23 | Borden, Inc. | Cheese-flavored substance and method of producing same |
US4816247A (en) * | 1985-09-11 | 1989-03-28 | American Cyanamid Company | Emulsion compositions for administration of sparingly water soluble ionizable hydrophobic drugs |
JPH01104050A (ja) | 1986-08-07 | 1989-04-21 | Medice Chem Pharm Fab Puetter Gmbh & Co Kg | 医薬製剤 |
DE3852409T2 (de) | 1987-01-27 | 1995-04-20 | Vestar Inc | Aus Phospholipiden bestehende Darreichungsform für wasserunlösliche Wirksubstanzen. |
DE68917544T2 (de) | 1988-06-20 | 1994-12-15 | Shiseido Co Ltd | Durchsichtiges Präparat. |
ES2052016T3 (es) * | 1988-09-29 | 1994-07-01 | Shiseido Co Ltd | Composicion emulsionada. |
FR2648462B1 (fr) * | 1989-06-15 | 1994-01-28 | Oreal | Procede pour ameliorer l'efficacite therapeutique de corticosteroides liposolubles et composition pour la mise en oeuvre de ce procede |
JP2785981B2 (ja) * | 1989-11-20 | 1998-08-13 | 株式会社資生堂 | 乳化組成物 |
DK0580778T3 (da) * | 1991-04-19 | 2000-01-31 | Lds Technologies Inc | Konvertible mikroemulsionsformuleringer |
US5688761A (en) * | 1991-04-19 | 1997-11-18 | Lds Technologies, Inc. | Convertible microemulsion formulations |
CA2114141A1 (en) * | 1991-07-26 | 1993-02-18 | Panayiotis Pericleous Constantinides | W/o microemulsions |
US5260065A (en) | 1991-09-17 | 1993-11-09 | Micro Vesicular Systems, Inc. | Blended lipid vesicles |
IL101007A (en) * | 1992-02-18 | 1997-08-14 | Pharmos Ltd | Dry stable compositions prepared by lyophilization |
IL101387A (en) | 1992-03-26 | 1999-11-30 | Pharmos Ltd | Emulsion with enhanced topical and/or transdermal systemic effect utilizing submicron oil droplets |
US5576016A (en) * | 1993-05-18 | 1996-11-19 | Pharmos Corporation | Solid fat nanoemulsions as drug delivery vehicles |
CH685674A5 (de) | 1993-12-19 | 1995-09-15 | Marigen Sa | Ultramikroemulsionen aus spontan dispergierbaren Konzentraten mit pharmakologisch wirksamen Estern von Apocarotinolen. |
MY129435A (en) * | 1994-10-26 | 2007-04-30 | Novartis Ag | Pharmaceutical microemulsion preconcentrates |
EP0711556A1 (de) * | 1994-11-09 | 1996-05-15 | Ciba-Geigy Ag | Intravenöse Lösungen für ein Staurosporinderivat |
EP0733358A3 (de) * | 1995-03-21 | 1998-05-20 | Novartis AG | Intravenös applizierbare Nanosuspensionen |
WO1996037192A1 (en) * | 1995-05-26 | 1996-11-28 | Vesifact Ag | Pharmaceutical and cosmetic compositions containing sphingo- and glycolipids |
DE19522693A1 (de) | 1995-06-22 | 1997-01-02 | Dianorm G Maierhofer Gmbh | Zusammensetzung zur Herstellung feindisperser Systeme und Verfahren zu ihrer Herstellung |
JP3508314B2 (ja) * | 1995-08-18 | 2004-03-22 | 大正製薬株式会社 | ビタミンcを配合した液剤 |
CA2238263A1 (en) * | 1995-12-12 | 1997-06-19 | Vesifact Ag | Cortisone spray for topical administration |
US6245349B1 (en) * | 1996-02-23 | 2001-06-12 | éLAN CORPORATION PLC | Drug delivery compositions suitable for intravenous injection |
EP0852941B1 (de) * | 1996-12-13 | 2003-05-14 | Vesifact Ag | Kosmetische Präparate in Form einer Nanodispersion |
US6028067A (en) * | 1997-12-05 | 2000-02-22 | Chong Kun Dang Corp. | Cyclosporin-containing microemulsion preconcentrate composition |
-
1999
- 1999-04-19 TW TW088106257A patent/TWI241915B/zh not_active IP Right Cessation
- 1999-04-23 MY MYPI99001603A patent/MY133019A/en unknown
- 1999-05-04 DE DE59912910T patent/DE59912910D1/de not_active Expired - Lifetime
- 1999-05-04 AT AT99810383T patent/ATE312597T1/de not_active IP Right Cessation
- 1999-05-04 EP EP99810383A patent/EP0956853B1/de not_active Expired - Lifetime
- 1999-05-04 PL PL99332934A patent/PL332934A1/xx unknown
- 1999-05-04 ES ES99810383T patent/ES2253871T3/es not_active Expired - Lifetime
- 1999-05-05 SG SG1999002127A patent/SG71923A1/en unknown
- 1999-05-06 ID IDP990417A patent/ID22565A/id unknown
- 1999-05-06 US US09/306,006 patent/US7081253B2/en not_active Expired - Lifetime
- 1999-05-07 AR ARP990102160A patent/AR019274A1/es active IP Right Grant
- 1999-05-10 CZ CZ991669A patent/CZ166999A3/cs unknown
- 1999-05-10 ZA ZA9903200A patent/ZA993200B/xx unknown
- 1999-05-10 CN CNB991063686A patent/CN1220483C/zh not_active Expired - Lifetime
- 1999-05-10 BR BRPI9902068A patent/BRPI9902068B8/pt not_active IP Right Cessation
- 1999-05-10 KR KR1019990016580A patent/KR100622285B1/ko active IP Right Grant
- 1999-05-10 AU AU28050/99A patent/AU767896B2/en not_active Ceased
- 1999-05-11 HU HU9901570A patent/HUP9901570A2/hu unknown
- 1999-05-11 RU RU99109958/15A patent/RU2224505C2/ru not_active IP Right Cessation
- 1999-05-11 JP JP12999099A patent/JP4755742B2/ja not_active Expired - Lifetime
-
2006
- 2006-06-05 US US11/446,844 patent/US7871642B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP0956853B1 (de) | 2005-12-14 |
CN1235017A (zh) | 1999-11-17 |
KR100622285B1 (ko) | 2006-09-11 |
JP4755742B2 (ja) | 2011-08-24 |
US7081253B2 (en) | 2006-07-25 |
AU767896B2 (en) | 2003-11-27 |
HUP9901570A2 (hu) | 2001-06-28 |
DE59912910D1 (de) | 2006-01-19 |
PL332934A1 (en) | 1999-11-22 |
CZ166999A3 (cs) | 1999-11-17 |
ID22565A (id) | 1999-11-11 |
BRPI9902068B8 (pt) | 2021-05-25 |
MY133019A (en) | 2007-10-31 |
EP0956853A3 (de) | 2000-01-05 |
HU9901570D0 (en) | 1999-07-28 |
CN1220483C (zh) | 2005-09-28 |
US20030190347A1 (en) | 2003-10-09 |
SG71923A1 (en) | 2000-04-18 |
BR9902068A (pt) | 2000-06-06 |
EP0956853A2 (de) | 1999-11-17 |
ES2253871T3 (es) | 2006-06-01 |
ATE312597T1 (de) | 2005-12-15 |
US20060292191A1 (en) | 2006-12-28 |
KR19990088156A (ko) | 1999-12-27 |
RU2224505C2 (ru) | 2004-02-27 |
ZA993200B (en) | 1999-11-11 |
US7871642B2 (en) | 2011-01-18 |
JPH11335266A (ja) | 1999-12-07 |
TWI241915B (en) | 2005-10-21 |
BR9902068B1 (pt) | 2014-10-29 |
AU2805099A (en) | 1999-11-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR019274A1 (es) | Uso de nanodispersiones en formulaciones farmaceuticas finales | |
ES2176661T3 (es) | Sistema de suministro para productos farmaceuticos envasados en vialesfarmaceuticos. | |
MY133152A (en) | Use of nanodispersions in cosmetic end formulations | |
ECSP003847A (es) | Composiciones farmaceuticas que proporcionan concentraciones potenciadas de farmaco | |
HN2000000267A (es) | Oxazolidinonas substituidas y su uso | |
AR026569A1 (es) | Auxiliar humectante concentrado pobre en espuma, su empleo y procedimiento para su elaboracion | |
ES2187200T3 (es) | Proteina hibrida para inhibir la desgranulacion de mastocitos y su uso. | |
AR024013A1 (es) | Preparado farmaceutico con diamorfina como sustancia activa, y su utilizacion en un procedimiento para el tratamiento de la adiccion a los opiaceos | |
UY29701A1 (es) | Formulaciones líquidas para la administración controlada de derivados de bencisoxazol | |
AR048965A1 (es) | Preparacion liquida de meloxicam e hidroyoduro de penetamato para medicina veterinaria, procedimiento para su produccion,y su uso | |
PE20011299A1 (es) | Emulsiones estables para productos cosmeticos | |
MX169328B (es) | Sistema para mezclar y distribuir concreto | |
CL2004001255A1 (es) | Formulacion liquida herbicida que contiene (a) uno o mas derivados de acidos policarboxilicos y (b) uno o mas compuestos activos inhibidores de als, procedimiento de para preparar la formulacion que comprende el mezclado de los componentes y metodo p | |
BRPI0413957A (pt) | processo para preparar diterpenos solúveis em água, solução aquosa e suas aplicações | |
AR045094A1 (es) | Formulaciones liofilizadas de cci-779 | |
AR020391A1 (es) | Formulaciones microencapsuladas, un procedimiento para su obtencion y empleo de dichas formulaciones. | |
PA8800101A1 (es) | Producto de dispersion sólida que contiene un compuesto a base de n-aril urea | |
ES2176452T3 (es) | Composicion para la liberacion controlada de ingredientes activos dependiente de ph y procedimientos para su fabricacion. | |
AR022273A1 (es) | Preparacion de evaporacion termica y metodo para evaporar sustancias quimicas por medio del uso de la misma | |
ES2171591T3 (es) | Nueva forma de dosificacion de hidroxocobalamina y su uso en el envenenamiento por cianuro. | |
CR6693A (es) | Pirazolo (4,3-e) diazepinas sustituidas novedosas, composiciones farmaceuticas que las contienen, su uso como productos medicinales y procesos para prepararlas | |
AR105691A1 (es) | Método, composición y conjunto de elementos para tratar la disfunción eréctil | |
HN2004000525A (es) | Forma de administracion transdermica liquida o semis lida que contiene sustancia activa sensible a la luz, estable a los rayos ultravioletas | |
AR241632A1 (es) | Procedimiento para preparar una composicion farmaceutica liquida de una 4-aroilimidazol-2-ona. | |
PA8528801A1 (es) | (7-(3-carboxifenil)-4-cloroisoquinolin-1-il)guanidina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration |